Stephen Kent invents new synthetic chemistries and uses them to elucidate the molecular basis of protein function. His early work focused on understanding the underlying physical chemical principles of polymer-supported peptide synthesis ('solid phase peptide synthesis'), and on identifying and eliminating the chemical side reactions... ...Read More>>

Robert Hodges  is Professor of Biochemistry & Molecular Genetics, Director, Program in Structural Biology and Biophysics and holder of the John Stewart Endowed Chair in Peptide Chemistry at the the University of Colorado Denver, School of Medicine, Aurora, CO, USA. Dr Hodges’ research spans diverse... ...Read More>>

In Jan. 2008-present, Dr. Alan Trounson was appointed President of the California Institute for Regenerative Medicine, responsible for the management of the $3 billion fund for stem cell research in California (CIRM) . Under his leadership CIRM has constructed 12 new Californian Stem Cell Research......Read More>>

Robert Parton studied biochemistry in the UK before moving to the European Molecular Biology Laboratory in Heidelberg, Germany. He received Royal Society and EMBO postdoctoral fellowships before becoming a group leader in 1990 studying plasma membrane domains and cell surface dynamics. In 1996, he moved... ...Read More>>

Mike Hann completed his PhD  on Isosteric replacement studies in Enkephalins in 1980 and then worked as a medicinal chemist at Wyeth and then GD Searle in the UK. Around 1983 Mike developed an interest in computational chemistry which was then emerging as a... ...Read More>>

Honorary Research Fellow, School of Biosciences, University of Birmingham, U.K. My current research efforts are focussed upon the development and applications of bioportides as a novel class of bioactive cell penetrating peptide (CPP). A variety of strategies have been employed to identify bioportide sequences that... ...Read More>>

Chris Porter is Professor of Pharmaceutics at the Monash Institute of Pharmaceutical Sciences and Associate Dean (Research) of the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University, Melbourne. He completed his undergraduate and graduate studies at the University of Nottingham before moving to Australia... ...Read More>>

Tomi Sawyer is Chief Scientific Officer and Senior Vice-President of Drug Discovery and Innovative Technologies at Aileron Therapeutics in Cambridge, Massachusetts, USA, and is engaged in the development of a new therapeutic modality based on transforming Nature’s α−helix to Stapled Peptide drugs. He is concurrently... ...Read More>>

Bob Millar is Director of the Mammal Research Institute at the University of Pretoria,  Director of the MRC Receptor Biology Unit at the University of Cape Town and Research Fellow at the Centre of Integrative Physiology at the University of Edinburgh. Previously he was Director... ...Read More>>

Scientia Professor Justin Gooding was born in Melbourne Australia.  He graduated with a B.Sc. (Hons) from Melbourne University before spending two years working for ICI Research on explosives.  He then returned to University obtaining a D.Phil. from the University of Oxford and received post-doctoral training... ...Read More>>

Dr. Schneider received his B.Sc. in chemistry from the University of Akron in 1991, followed by a Ph.D. (1995) in chemistry from Texas A&M University.  After which, he became a George W. Raiziss Postdoctoral Fellow at the University of Pennsylvania (1996-1999) studying protein design.  He... ...Read More>>

Prof. Lee has received B. S. degree from Seoul National University (1974), and Ph. D from Rutgers University in organic chemistry (1981). He worked as a Post Doc. in the Department of Chemistry at the University of Chicago (1981-82). He is now a professor... ...Read More>>

Professor Morten Meldal currently Head of the Nano Science Center at Copenhagen University, Copenhagen, Denmark. In 1981 he graduated as M.Sc. in Chemical Engineering from Technical University of Denmark. He took his PhD 1983 at Institute of Organic Chemistry, Technical University of Denmark, in "Synthesis... ...Read More>>

William Hildebrand characterizes the number and nature of peptides presented by the class I human leukocyte antigens (HLA) of cancerous and infected cells.  HLA class I molecules are responsible for conveying the internal health of human cells to the immune system.  Class I HLA accomplish... ...Read More>>

Professor Michael Parker is Deputy Director of St. Vincent’s Institute of Medical Research in Melbourne where he is heads its Structural Biology Laboratory and the ACRF Rational Drug Discovery Centre. He is an NHMRC Senior Principal Research Fellow and a Professorial Fellow at the Bio21... ...Read More>>

Professor Mark Wheatley was appointed to the position of Chair of Biochemical Pharmacology in 2007 within the School of Biosciences at the University of Birmingham in the UK. His research addresses the structure and function of G-protein-coupled receptors (GPCRs) particularly those with peptide ligands. Understanding... ...Read More>>

Charlotte A.E. Hauser was trained in Chemistry at the University of Cologne, Germany, and did her Ph.D. in Molecular Biology at the Massachusetts Institute of Technology, USA. Following this, she joined INSERM in Paris, France, and the Max-Planck-Institute of Psychiatry in Munich, Germany. She is... ...Read More>>

My research involves exploring the potential of peptides as drug candidates for therapeutic applications. Despite the significant potential of peptides in drug design because they can be highly potent and specific for a range of different drug targets, their inherent poor stability limits their application.... ...Read More>>

Prof Dr Iekhsan Othman is currently Deputy Head of School for Research and Head of Biomedical Sciences in the Jeffery Cheah School of Medicine and Health Sciences, Monash University, Sunway Campus, Malaysia.. He holds a BSc (Hons)  in biochemistry from Bristol University and a doctorate... ...Read More>>

James P. Tam is the Director of the Drug Discovery Laboratory at Nanyang Technological University, Singapore.  He was the founding dean of the School of Biological Sciences, founding director of the double-degree program in Biomedical Science and Chinese Medicine, and the founding director of NTU......Read More>>

Philip Dawson is an Associate Professor in the Departments of Chemistry and Cell and Molecular Biology at The Scripps Research Institute (TSRI) in La Jolla, CA and is also the Associate Dean of Graduate Studies for the Kellogg School of Science and Technology at... ...Read More>>

Date of birth: December 14, 1960. EDUCATION: B.S.: Tokyo University of Pharmacy, Tokyo, Japan; graduated in March 1983. M.S.: Faculty of Pharmaceutical Science, Kyoto University, Kyoto, 1983-1985. Ph.D. Faculty of Pharmaceutical Science, Kyoto University, Kyoto, 1990, under the guidance of Emeritus Professor Haruaki Yajima and Professor... ...Read More>>

Prof Matthew Cooper completed his PhD in Australia in 1995 and then spent 13 years in the UK, first at the University of Cambridge, then 9 years in start-ups and biotechnology companies. This involved innovation, fund raising, intellectual property generation, licensing, product development and commercialisation. ... ...Read More>>

Laszlo’s current research focuses on the development of antimicrobial peptides to resistant infections as well as agonists and antagonists to adipokine receptors.  His first-of-kind and optimized peptide analogs show promising preclinical advantages over conventional therapy against not only bacterial infections, but also metabolic and cardiovascular diseases,......Read More>>

Christie Hunter is the Director of Proteomic Applications at AB SCIEX. Christie and her team are focused on developing and testing innovative MS workflows for the quantitative analysis of proteins and peptides, and work collaboratively with the instrument, chemistry and software research groups. Her primary... ...Read More>>

David Jackson has been an active researcher over the last 35 years in the areas of immunology and immunochemistry. His recent research efforts are focused on the design, assembly and evaluation of new and innovative vaccines which have resulted in pre-clinical as well as... ...Read More>>

Dr. Yan-Mei LI, Professor, Director of Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology (Ministry of Education). She graduated from Tsinghua University and received Ph.D. in 1992 under the supervision of Professor Yu-Fen Zhao. Then she worked with Prof. Dr. H. Waldmann as post-doctoral... ...Read More>>

*Dr Abdiche* is a Research Fellow at Pfizer’s biotherapeutic site in South San Francisco, California, formerly Rinat Neuroscience, which she joined in 2004. She leads the Biosensor Group within Protein Engineering that supports multiple projects at all stages of research using complementary label-based and label-free technologies... ...Read More>>